question: Is the monoclonal antibody Trastuzumab (Herceptin) of potential use in the treatment of prostate cancer?
answer: Although is still controversial, Trastuzumab (Herceptin) can be of potential use in the treatment of prostate cancer overexpressing HER2, either alone or in combination with other drugs.